Kevin P. Kerns

Array ( [id] => 5010463 [patent_doc_number] => 20070280942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 11/748370 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 46877 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20070280942.pdf [firstpage_image] =>[orig_patent_app_number] => 11748370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 161723 [patent_doc_number] => 07670602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Concatameric immunoadhesion molecule' [patent_app_type] => utility [patent_app_number] => 11/739288 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 19003 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/670/07670602.pdf [firstpage_image] =>[orig_patent_app_number] => 11739288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 236058 [patent_doc_number] => 07595038 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-29 [patent_title] => 'Methods of treatment using antibodies to follistatin-3' [patent_app_type] => utility [patent_app_number] => 11/738846 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 81566 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/595/07595038.pdf [firstpage_image] =>[orig_patent_app_number] => 11738846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575945 [patent_doc_number] => 20100047204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'USE OF ORGANIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/297084 [patent_app_country] => US [patent_app_date] => 2007-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7067 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047204.pdf [firstpage_image] =>[orig_patent_app_number] => 12297084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 168845 [patent_doc_number] => 07667002 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Peptides and proteins for early liver development and antibodies thereto' [patent_app_type] => utility [patent_app_number] => 11/783459 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 39 [patent_no_of_words] => 20951 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/667/07667002.pdf [firstpage_image] =>[orig_patent_app_number] => 11783459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10534895 [patent_doc_number] => 09260516 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Method for promoting muscle regeneration by administering an antibody to the IL-6 receptor' [patent_app_type] => utility [patent_app_number] => 12/296193 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11838 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12296193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5125505 [patent_doc_number] => 20070237776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'High affinity human antibodies to human IL-18 receptor' [patent_app_type] => utility [patent_app_number] => 11/784308 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9858 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237776.pdf [firstpage_image] =>[orig_patent_app_number] => 11784308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038362 [patent_doc_number] => 20110091411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Interleukin-1 Muteins Linked to Virus-Like Particles to Treat IL-1 Associated Diseases' [patent_app_type] => utility [patent_app_number] => 12/443344 [patent_app_country] => US [patent_app_date] => 2007-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 36449 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091411.pdf [firstpage_image] =>[orig_patent_app_number] => 12443344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5187972 [patent_doc_number] => 20070166280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'CHEMOKINES AS ADJUVANTS OF IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 11/692636 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13083 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166280.pdf [firstpage_image] =>[orig_patent_app_number] => 11692636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5125472 [patent_doc_number] => 20070237743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Combination therapies using low-toxicity, long-circulating human interferon-alpha analogs' [patent_app_type] => utility [patent_app_number] => 11/728133 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14740 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237743.pdf [firstpage_image] =>[orig_patent_app_number] => 11728133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4580926 [patent_doc_number] => 07834152 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Antagonists of interleukin-15' [patent_app_type] => utility [patent_app_number] => 11/726086 [patent_app_country] => US [patent_app_date] => 2007-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 33 [patent_no_of_words] => 17922 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/834/07834152.pdf [firstpage_image] =>[orig_patent_app_number] => 11726086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5027988 [patent_doc_number] => 20070269435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Artificial proteins with reduced immunogenicity' [patent_app_type] => utility [patent_app_number] => 11/716878 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 34518 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269435.pdf [firstpage_image] =>[orig_patent_app_number] => 11716878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585944 [patent_doc_number] => 20090105146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'PROTEINS, NUCLEIC ACIDS AND MEDICAMENTS' [patent_app_type] => utility [patent_app_number] => 12/282463 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 26492 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105146.pdf [firstpage_image] =>[orig_patent_app_number] => 12282463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4978123 [patent_doc_number] => 20070219357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Chemically modified G-CSF' [patent_app_type] => utility [patent_app_number] => 11/716866 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5725 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219357.pdf [firstpage_image] =>[orig_patent_app_number] => 11716866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452148 [patent_doc_number] => 20090068185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Asthma associated factors as targets for treating atopic allergies including asthma and related disorders' [patent_app_type] => utility [patent_app_number] => 11/716051 [patent_app_country] => US [patent_app_date] => 2007-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 19077 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068185.pdf [firstpage_image] =>[orig_patent_app_number] => 11716051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652145 [patent_doc_number] => 20080039401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Interleukin-9 mutein peptides' [patent_app_type] => utility [patent_app_number] => 11/714899 [patent_app_country] => US [patent_app_date] => 2007-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 25853 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039401.pdf [firstpage_image] =>[orig_patent_app_number] => 11714899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6252007 [patent_doc_number] => 20100028350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'PREVENTING IL-2 MEDIATED INFLAMMATION IN EPITHELIAL CELLS' [patent_app_type] => utility [patent_app_number] => 12/281474 [patent_app_country] => US [patent_app_date] => 2007-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11426 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028350.pdf [firstpage_image] =>[orig_patent_app_number] => 12281474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146477 [patent_doc_number] => 08163482 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'BBS10 related diagnostic methods for Bardet-Biedl syndrome' [patent_app_type] => utility [patent_app_number] => 12/280498 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 12 [patent_no_of_words] => 19811 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163482.pdf [firstpage_image] =>[orig_patent_app_number] => 12280498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247355 [patent_doc_number] => 20070243589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Antibodies against human IL-22 and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/708061 [patent_app_country] => US [patent_app_date] => 2007-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 85 [patent_no_of_words] => 31572 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243589.pdf [firstpage_image] =>[orig_patent_app_number] => 11708061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6614368 [patent_doc_number] => 20100310501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian Subject' [patent_app_type] => utility [patent_app_number] => 12/279264 [patent_app_country] => US [patent_app_date] => 2007-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 39832 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310501.pdf [firstpage_image] =>[orig_patent_app_number] => 12279264 [rel_patent_id] =>[rel_patent_doc_number] =>)